All Studies Meta Analysis

Evaluation of Efficacy of Pharmacotherapy Treatment of COVID- 19 Infection Using Oral Levamisole and Formoterol+Budesonide Inhaler and Comparison of This Treatment Protocol With Standard National Treatment of the Disease

Afazeli et al., NCT04331470, NCT04331470

May 2020

Post
Facebook

Source PDF All Studies Meta AnalysisMeta

Budesonide for COVID-19

19th treatment shown to reduce risk in April 2021, now with p = 0.0000011 from 15 studies, recognized in 8 countries.

Lower risk for mortality, ICU admission, hospitalization, progression, recovery, and cases.

No treatment is 100% effective. Protocols combine treatments.

5,100+ studies for 109 treatments. c19early.org

Estimated 30 patient budesonide early treatment RCT with results not reported over 4 years after estimated completion.

4 budesonide RCTs have results missing long after expected1-4
The trials report a total of 916 patients, with 1 trial having actual enrollment of 146, and the remainder estimated.

Important missing comments or errors? Let us know.

1. Marcy et al., Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection: A Multi-Arm Multi-Stage Randomized Trial (MAMS) to Evaluate the Effectiveness of Several Specific Treatments in Reducing the Risk of Clinical Worsening or Death in Sub-Saharan Africa (COVERAGE-Africa), NCT04920838, clinicaltrials.gov/study/NCT04920838.clinicaltrials.gov.

2. Korea United Pharm., A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 2 Study to Evaluate the Efficacy and Safety of UI030 in COVID-19 Patients, NCT05055414, clinicaltrials.gov/study/NCT05055414.clinicaltrials.gov.

3. Taille et al., Protective Role of Inhaled Steroids for Covid-19 Infection, NCT04331054, clinicaltrials.gov/study/NCT04331054.clinicaltrials.gov.

4. Afazeli et al., Evaluation of Efficacy of Pharmacotherapy Treatment of COVID- 19 Infection Using Oral Levamisole and Formoterol+Budesonide Inhaler and Comparison of This Treatment Protocol With Standard National Treatment of the Disease, NCT04331470, clinicaltrials.gov/study/NCT04331470.clinicaltrials.gov.

Afazeli et al., 20 May 2020, Double Blind Randomized Controlled Trial, Iran, trial NCT04331470 (history). Contact: Dr.afazeli@gmail.com, farjam.md@gmail.com, info@fums.ac.ir.

This Paper Budesonide All

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0